Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13 Disclosures
  • [Disclosure] Samsung Biologics (207940) – (Correction) Single Sales and Supply Contract / 2025-11-13 Disclosures
  • [Disclosure] Wonik IPS (240810) – Change in Sales or Profit/Loss Structure by More Than 30% (15% for Large Companies) / 2024-02-21 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Resolution on Convocation of General Meeting of Shareholders / 2026-03-16 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – Daishin Securities | 3Q Solid Results · AI & Automotive Mix · 2025 Profit Recovery / 2024-10-30 RESEARCH
  • [Disclosure] Samsung Electro-Mechanics (009150) – Matters Related to Sustainability Report (Voluntary Disclosure) / 2024-06-28 Semiconductors
  • [Disclosure] HPSP (403870) – Report on Reason for Holding Shareholder Meeting on Concentrated Date / 2025-03-13 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Holding of Investor Relations (IR) Session / 2024-11-08 Disclosures

[Disclosure] Celltrion (068270) – Decision on Cash and Goods Dividend / 2025-12-11

Posted on December 11, 2025August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion has decided on a year-end cash dividend of KRW 750 per common share (totaling approx. KRW 164.0B, dividend yield of 0.4%) for FY2025, funded by capital reserve reduction for tax-exempt status.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Decision on Cash and Goods Dividend
  • Dividend Type & Method: Year-end dividend / Cash dividend (Differential dividend: N/A)
  • Dividend per Share: KRW 750 (Common shares)
  • Dividend Yield: 0.4% (Based on 1-week arithmetic average price prior to the Board resolution date)
  • Total Dividend Amount: KRW 163,959,843,000 (approx. KRW 164.0B)
    • Target Shares: 218,613,124 shares (Total 230,960,969 issued shares minus 12,347,845 treasury shares)
  • Record Date: December 31, 2025
  • Board Resolution Date: December 11, 2025 (All 8 outside directors attended)
  • General Meeting & Payment Schedule:
    • General Shareholders’ Meeting: To be held (Specific date unconfirmed as of disclosure date)
    • Scheduled Payment Date: Within one month after approval at the Annual General Meeting (pursuant to Article 464-2 of the Commercial Code)
  • Taxation & Legal Notes:
    • Funded by a portion of capital reserves reduced via resolution at the 34th AGM on March 25, 2025
    • Exempt from taxable income under relevant tax laws (Enforcement Decree of the Income Tax Act Article 26-3, Corporate Tax Act Article 18)

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of AGM Approval and Tax-Exempt Cash Dividend Payment Execution

This disclosure details Celltrion’s decision to pay a year-end cash dividend of KRW 750 per common share utilizing capital reserve reduction to provide tax-free dividend income, making it important to monitor the approval at the AGM and execution of payment within one month following the meeting. Tracking shareholder approval and payment confirms the completion of shareholder return policies. Final approval and payment schedules can be verified through future ‘Resolution on Convocation of General Shareholders’ Meeting’ and ‘Results of General Shareholders’ Meeting’ disclosures.

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Decision on Acquisition of Shares and Equity Securities of Other Corporation (Correction) / 2025-12-11
Next Post: [Disclosure] Celltrion (068270) – Decision on Closure of Shareholders’ Register (Record Date) for Cash/Goods Dividend / 2025-12-11

Related Posts

  • [Disclosure] Hanmi Semiconductor (042700) – Matters Related to Timely Disclosure Obligations (Fair Disclosure) / 2026-01-02 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Results of Annual General Meeting / 2025-03-25 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Cash/In-Kind Dividend / 2026-01-28 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Execution of Sales / Supply Contract / 2026-06-19 Disclosures
  • [Disclosure] Samsung Electronics(005930) – Decision on Cash and In-Kind Dividend / 2024-01-31 Disclosures
  • [Disclosure] Wonik IPS (240810) – Consolidated Financial Results (Provisional) / 2025-02-26 Semiconductors
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product (ALT-B4) / 2026-03-25 Bio & Healthcare
  • [Research] Samsung Electro-Mechanics (009150) – Mirae Asset Securities | High MLCC & Substrate Utilization · Off-Season Headwinds Easing · Target EV/EBITDA Re-rating / 2025-10-30 RESEARCH
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Announcement / 2025-01-08 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Board Resolution on Convening Extraordinary General Shareholders Meeting / 2024-11-18 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Change in Profit and Loss Structure Exceeding 30% (15% for Large Corporations) / 2024-01-24 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Other Management Matters (Voluntary Disclosure) / 2025-10-30 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Outlook on Sales Performance, Etc. (Fair Disclosure) / 2025-01-03 Disclosures
  • [Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2024-12-26 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme